Author: Chris Walster BVMS, MVPH, CertAqV, MRCVS
A letter to the editor in the Australian Veterinary Journal on dwindling antibiotic options for Australian veterinarians prompted this piece. In my view, access to suitable antibiotics deserves more attention in aquatic veterinary medicine. Where few products are authorised for the species and conditions we treat, responsible prescribing depends on what we can obtain in time, in the right quantity and in a form the animals can receive. [1]
The hypothetical examples in this piece refer to aquaculture, but the same questions arise when treating ornamental fish and other aquatic animals. Can we obtain a suitable antibiotic, in a quantity that fits the case and in a formulation we can administer reliably?
Imagine a hatchery facing a bacterial outbreak. The veterinarian identifies a suitable antibiotic, but the supplier cannot deliver it in time. If it can be sourced, the feed mill’s smallest order might still exceed what the affected group needs. And even if the right quantity arrives, sick fish may eat too little to receive the intended dose. Each of these problems can make antimicrobial stewardship harder. Stewardship means avoiding unnecessary use and using antimicrobials responsibly when treatment is needed, helping to preserve their effectiveness and limit antimicrobial resistance (AMR). [2, 3, 4]
As the world’s population grows, aquaculture has an increasingly important role in supplying aquatic foods. When bacterial infections in food-producing animals become harder to treat because of AMR, illness and deaths can reduce production. Timely access to suitable antibiotics matters for animal welfare and food production when treatment is needed. [2, 8]
This is a One Health issue because animal, human and environmental health are connected. In aquaculture, the water in which animals are treated can also carry antibiotic residues and resistant bacteria beyond the farm. Stewardship means preventing infections where possible and making effective treatment available when needed, while limiting unnecessary use and exposure in the surrounding environment. [2, 4]
The first prescribing question is often whether there is a lawful option for the species and condition being treated. The second is whether it can reach the farm in time. A product listed in a national register may be out of stock locally or have a lead time that makes it impractical. The World Organisation for Animal Health (WOAH) documents differences across regions in how antibiotics are authorised and used in food-producing fish and crustaceans. [1]
In Australia, the Australian Pesticides and Veterinary Medicines Authority provides searches for registered products and permits. South Australia also has an application process for aquaculture licence holders proposing use outside a medicine’s approved terms, known as off-label use. In the European Union, Article 114 of Regulation (EU) 2019/6 sets out a conditional pathway for the veterinarian where no veterinary medicine is authorised in the Member State for an indication in a food-producing aquatic species. Check the rules where the animals are treated and confirm actual stock and delivery times with the supplier. [5, 6, 7]
Access to medicines is only one part of access to appropriate treatment. In a WOAH case study in Bangladesh, some surveyed aquaculture farmers described antibiotics as readily available while reporting cost barriers to professional services and laboratory diagnosis. In a separate interview study, Australian companion animal veterinarians described how the medicines they could readily obtain influenced what they chose. That finding gives aquatic teams a question to investigate in their own setting: when has a supply gap delayed treatment or changed the choice of drug? [8, 9]
A manufacturer’s pack of concentrated premix, a feed mill’s minimum order of finished medicated feed and the quantity prescribed for a group are three separate figures. The US label for Aquaflor, for example, lists a 2 kg pouch of florfenicol premix for making medicated feed for freshwater-reared finfish. A hatchery treating a small group should ask the mill how much finished feed it can supply in its smallest order. If that exceeds the prescribed quantity, the farm may face a higher upfront cost and have surplus feed to manage. [10]
The European Medicines Agency recommends pack sizes that allow accurate dosing for different animal sizes and group sizes while limiting leftovers. Its guidance also recognises the practical and economic constraints of offering many pack sizes. In the Bangladesh case study, 34% of respondents reported saving antibiotics for later use when they had leftovers. The survey leaves open why those leftovers arose and whether changes to pack size would affect resistance development. [8, 11]
Medicated feed can deliver treatment to a group, provided the fish eat enough of it. Infection can reduce appetite, and fish may eat less if they find the medicated pellets unpalatable. A review focused on European seabass and gilthead seabream in Mediterranean aquaculture also describes how some coating methods can increase leaching, the loss of antibiotic from pellets into the water. Even if an order contains the prescribed quantity, some fish may receive less than intended. How much reaches them depends on factors including the formulation, how the feed is made and how readily the fish eat it. [4]
Ask whether the available formulation suits the species, life stage and feeding behaviour of the group. When medicated feed is prescribed, agree with the fish health team how to monitor intake and when to review the plan if fish are eating less than expected. [2, 4]
For further learning, WAVMA’s One Health in aquaculture webinar explores AMR and alternatives to antibiotics in aquaculture. The training requires a WAVMA membership to obtain free access or a fee applies to guests.
At your next fish health planning meeting, review one recent antibiotic order with your veterinarian, farm team and feed supplier. Record what was prescribed, what could be obtained and how quickly, the smallest quantity the supplier could deliver and how well the formulation suited the fish. Agree how any surplus should be handled under local rules. If the same gap keeps recurring, share a de-identified example with the relevant supplier, manufacturer or regulator so they can see where supply, pack size or formulation falls short. [2, 11]
Has your team found a way to source a suitable antibiotic, order smaller quantities or improve dose delivery? Tell us what worked and where gaps remain. Send a comment or article for consideration by The Aquatic Veterinarian or contact WAVMA’s e-News editors about a contribution to the WAVMA blog. Publication is at the relevant editor’s discretion. WAVMA members can also discuss their experiences through the member listservs.